What do systematic reviews say?

Summary of findings table ‐ Social activities vs usual care

The review found no eligible studies for this question.

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Social activities vs usual care

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 236 participants
  Low

Summary of findings table ‐ Social activities vs usual care

The review found no eligible studies for this question.

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Social activities vs usual care

The review found no eligible studies for this question.

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Light therapy vs usual care

The review found no eligible studies for this question.

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Social activities vs usual care

The review found no eligible studies for this question.

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Social activities vs usual care

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 236 participants
  Low

Summary of findings table ‐ Light therapy vs usual care

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  7 studies · 133 participants
  Very low

Summary of findings table ‐ Light therapy vs usual care

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 205 participants
  Very low

Summary of findings table ‐ Light therapy vs usual care

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 136 participants
  Very low

Summary of findings table ‐ Light therapy vs usual care

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 3 participants
  Low

Summary of findings table ‐ Light therapy vs usual care

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  7 studies · 318 participants
  Very low

Summary of findings table ‐ Physical activities vs usual care

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 167 participants
  Low

Summary of findings table ‐ Physical activities vs usual care

The review found no eligible studies for this question.

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intravenous tranexamic acid vs placebo

Intravenous tranexamic acid may leads to lower risk of requiring allogeneic blood transfusion (30 days post‐surgery) compared with placebo (low certainty).

• Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint… 2023 · Cochrane Headline outcomes only
  RR 0.48 [0.34, 0.69]
  6 studies · 457 participants
  Low

Antifibrinolytic therapy - locally-applied tranexamic acid (TXA) mouthwash/solution (SoF eligibility: TXA or EACA; all included trials used topical TXA) vs placebo

The review found no eligible studies for this question.

• Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Antifibrinolytic therapy - locally-applied tranexamic acid (TXA) mouthwash/solution (SoF eligibility: TXA or EACA; all included trials used topical TXA) vs placebo

It is very uncertain whether topical tranexamic acid changes risk of myocardial infarction (30 days post‐surgery) compared with placebo (very low certainty).

• Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint… 2023 · Cochrane Headline outcomes only
  Peto OR 0.15 [0, 7.62]
  1 study · 36 participants
  Very low

Antifibrinolytic therapy - locally-applied tranexamic acid (TXA) mouthwash/solution (SoF eligibility: TXA or EACA; all included trials used topical TXA) vs placebo

It is very uncertain whether topical tranexamic acid changes risk of cerebrovascular accident/stroke (30 days post‐surgery) compared with placebo (very low certainty).

• Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint… 2023 · Cochrane Headline outcomes only
  RD 0
  1 study · 65 participants
  Very low

Antifibrinolytic therapy - locally-applied tranexamic acid (TXA) mouthwash/solution (SoF eligibility: TXA or EACA; all included trials used topical TXA) vs placebo

It is very uncertain whether topical tranexamic acid changes risk of deep vein thrombosis (30 days post‐surgery) compared with placebo (very low certainty).

• Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint… 2023 · Cochrane Headline outcomes only
  Peto OR 1.11 [0.07, 17.77]
  2 studies · 101 participants
  Very low

Antifibrinolytic therapy - locally-applied tranexamic acid (TXA) mouthwash/solution (SoF eligibility: TXA or EACA; all included trials used topical TXA) vs placebo

The review found no eligible studies for this question.

• Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found